Paraventricular nucleus-microinjected glucose increases food intake in 18 h food-deprived rats: A central regulatory mechanism on serum ghrelin and leptin levels.


Journal

European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354

Informations de publication

Date de publication:
05 Jun 2020
Historique:
received: 19 01 2020
accepted: 13 03 2020
pubmed: 20 3 2020
medline: 13 1 2021
entrez: 20 3 2020
Statut: ppublish

Résumé

Our previous study demonstrated that glucose acts in hypothalamic paraventricular nucleus (PVN) to increase gastric acid secretion. However, there is no evidence to show the role of the hypothalamic PVN-microinjected glucose on food intake. On the other hand, it is known that ghrelin and leptin play important roles in food intake. The current study investigated the association between PVN-microinjected glucose and food intake and plasma ghrelin-leptin levels. After the PVN microinjection of glucose, food intake was measured. In other groups, ELIZA kits were used to obtain ghrelin, leptin, insulin and glucose concentrations. All experiments were done in18 h food-deprived rats. The findings revealed that the PVN-microinjected glucose increased food intake in a dose-dependent manner. The stimulatory effect of glucose persisted for more than 2 h. Interestingly, it was found that PVN microinjection of glucose stimulates plasma ghrelin and decreases plasma leptin levels without any effect on plasma insulin and glucose concentrations over 1 h. The results of the present study suggest that the PVN glucose-mediated cells may be involved in the regulatory mechanisms of food intake. This stimulatory effect seems to be mediated, at least in part, through central nervous system regulatory mechanisms of plasma leptin and ghrelin levels.

Identifiants

pubmed: 32188577
pii: S0014-2999(20)30165-5
doi: 10.1016/j.ejphar.2020.173073
pii:
doi:

Substances chimiques

Ghrelin 0
Leptin 0
Glucose IY9XDZ35W2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

173073

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors confirm that there is no conflict of interest. MSB, FN and AH performed the research. AE and MSB analyzed the data. AE designed the research study and wrote the paper.

Auteurs

Masoud Shareghi Brojeni (MS)

Neurophysiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Fatemeh Nasseri (F)

Department of Physiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abbas Haghparast (A)

Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Afsaneh Eliassi (A)

Neurophysiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Physiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: af.eliassi@sbmu.ac.ir.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH